Seal M

No ORCID on file · 1 paper in corpus
2023
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol30100678

Pathogenic variants (PVs) in BRCA1 and BRCA2 increase the lifetime risks of breast and ovarian cancer. Guidelines recommend breast screening (magnetic resonance imaging (MRI) and mammogram) or risk-reducing mastectomy (RRM) and salpingo-oop…